Russell Investments Group
TNGX icon

Russell Investments Group’s Tango Therapeutics TNGX Stock Holding History

Russell Investments Group’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$269K Buy
12,840
+3,046
+31% +$42.4K ﹤0.01% 2749
2025
Q4 		$86.8K Buy
9,794
+2,065
+27% +$17.8K ﹤0.01% 3091
2025
Q3 		$64.9K Buy
7,729
+6,352
+461% +$43K ﹤0.01% 3176
2025
Q2 		$7.05K Sell
1,377
-49,806
-97% -$123K ﹤0.01% 3393
2025
Q1 		$72.9K Buy
51,183
+49,116
+2,376% +$121K ﹤0.01% 2828
2024
Q4 		$6.39K Buy
2,067
+1,998
+2,896% +$9.28K ﹤0.01% 3230
2024
Q3 		$531 Buy
69
+38
+123% +$363 ﹤0.01% 3569
2024
Q2 		$266 Hold
31
– – ﹤0.01% 3538
2024
Q1 		$246 Hold
31
– – ﹤0.01% 3266
2023
Q4 		$307 Hold
31
– – ﹤0.01% 3154
2023
Q3 		$349 Sell
31
-34,412
-100% -$210K ﹤0.01% 3434
2023
Q2 		$114K Buy
+34,443
New +$124K ﹤0.01% 2583

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Russell Investments Group's TNGX Position: Q1 2026 in Review

Russell Investments Group increased its Tango Therapeutics (TNGX) stake by 31% in Q1 2026, buying an estimated $42.4K and bringing the position to 12,840 shares worth $269K. The position accounts for ﹤0.01% of the portfolio, ranked #2749.

Russell Investments Group first reported a position in TNGX in Q2 2023 and has held it in 12 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Russell Investments Group held 12,840 shares of Tango Therapeutics worth $269K as of Q1 2026.
  • Russell Investments Group bought 3,046 Tango Therapeutics shares in Q1 2026, an estimated $42.4K.
  • Tango Therapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #2749 holding.
  • Russell Investments Group first reported a position in Tango Therapeutics in Q2 2023 and has held it in 12 quarters since.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.